J, Y., H, Z., W, W., Q, Y., X, H., D, T., . . . B, L. (2025). CD80 Antibody and MTX Co-Engineered Extracellular Vesicles Targets CD80+ Macrophages to Suppress Inflammation and Alleviate Chronic Inflammatory Diseases. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Yang, et al. CD80 Antibody and MTX Co-Engineered Extracellular Vesicles Targets CD80+ Macrophages to Suppress Inflammation and Alleviate Chronic Inflammatory Diseases. Dove Medical Press, 2025.
MLA (9th ed.) CitationJ, Yang, et al. CD80 Antibody and MTX Co-Engineered Extracellular Vesicles Targets CD80+ Macrophages to Suppress Inflammation and Alleviate Chronic Inflammatory Diseases. Dove Medical Press, 2025.
Warning: These citations may not always be 100% accurate.